not receiving any information about the fertility risks of TKI by their medical team. Eighteen (24%) considered FP prior to their cancer therapy, and 8 (11%) attempted FP. When comparing desire to have a child to FP service seeking, 54% of those who desired children in the future considered FP compared to 8% in those who didn't wish to have children in the future (p<0.001), and 27% of those who desired children in the future attempted FP compared to 2% in those who didn't wish to have children in the future (p[0.001). Regarding decision satisfaction regarding FP, 23% of those who desired children in the future disagreed with "I made the right decision" compared to 3% in those who did not wish to conceive (p[0.003); similarly, 19% of those who wished to have children in the future agreed with "I regret the choice I made", compared to 6% in those who did not (p[0.09).
INTRODUCTION AND OBJECTIVES:
Although an increasing number of gay men are seeking parenthood using an egg donor and a gestational carrier (GC), no studies have evaluated the reproductive concerns of gay men. The aim of this study is to explore the main areas of concern for gay men who have children through third party reproduction, and to use that information to create a quantitative, evidencebased survey tool to assess the needs of gay men interested in paternity.
METHODS: Six gay males in the Salt Lake City area who had previously had children using a GC completed semi-structured interviews and provided written answers (multiple choice and openended questions) to different areas of concern specific to this population: sperm usage/male factor infertility, egg donation, surrogacy, legal issues, and financial burden. Interview and written answers were aggregated and analyzed.
RESULTS: The mean age of the participants was 44AE6.6 years. All men had been in committed relationships for at least 2 years (mean 9AE6) prior to deciding to have children. The majority of the men had a college (5, 83%) or post-graduate degree (4, 67%). 50% found it difficult to understand the procedures involved in third party reproduction. None of the men had issues with male factor infertility. 50% used sperm from one partner while 50% used sperm from both partners and had more than one child. For 83%, third party reproduction was illegal in their state of residence, so they traveled to an out-of-state fertility center. 33% encountered legal issues (i.e. inability to get both names on a birth certificate) or had difficulties with a reproductive attorney. For 83%, financial considerations were significant, and 50% saved money for 2-5 years before seeking fertility services. When asked what part of the process was the most anxiety-provoking, a variety of answers were provided: 33% noted the cost of the process, 50% the health of the baby, and 33% the unknowns with regards to the GC, such as fear that she would not give up her rights to the child. 50% of the men expressed being overwhelmed by the long and complex process.
CONCLUSIONS: Gay men seeking biological children face unique reproductive challenges, such as the process of surrogacy and the inevitable legal and financial issues involved. A large-scale analysis is needed to build an evidence-based survey tool to assess the needs of gay men that can highlight the specific needs of the couple and facilitate an individualized approach to treatment.
Source of Funding: None

MP46-10 AN AT-HOME SYSTEM THAT ADAPTS TO DIFFERENT TYPES OF MOBILE PHONES FOR MEASURING SPERM MOTILITY-VERIFICATION OF ITS PERFORMANCE OF ARTIFICIAL INTELLIGENCE (AI) SPERM IMAGE RECOGNITION WITH CLOUD COMPUTING
Vincent Tsai*, Taoyuan, Taiwan; Bin Zhuang, Shenzhen, China, People's Republic of INTRODUCTION AND OBJECTIVES: According to reports of WHO, human sperm quality fluctuates at different times. Therefore, it is crucial for couples preparing for spontaneous pregnancy to monitor sperm motility. CreateCare POC testing corporation has developed the world's first mobile phone based at-home sperm motility measurement system (BemanerÒ). This system is composed of microscope and microfluidic modules and is designed to adapt to different types of mobile phone designs and interfaces. The sperm videos are captured and uploaded to the cloud from mobile phones with our accompanied applications. Analysis of sperm motility is performed by AI sperm image recognition with cloud computing, and the results are displayed on the mobile interfaces of our customers. This study is to verify the performance of AI sperm image recognition and the cloud computation system.
METHODS: According to the number of motile sperm in the vision field of each video, the forty-seven delinked sperm videos (subjects unidentified) are classified into 6 grades (0-5) by a malefertility expert with 10 years of experience. Correlation is calculated by Excel (MicrosoftÒ 2016) between the assessed grades and the results (concentration of motile sperm, total motility and pregnancy index) computed by AI sperm image recognition based on cloud computing.
RESULTS: Good correlations have been shown between the assessed grades and results (concentration of motile sperm, total motility, and pregnancy index) computed by the system and the AI algorithm (v 1.0.8_5/22). The respective correlation coefficients are 0.84, 0.90, and 0.83 and our calculated p value are all below 0.01.
CONCLUSIONS: This mobile based at-home system for measuring sperm motility (BemanerÒ) accurately measures parameters related to sperm motility, and could potentially be applied towards the following fields: male infertility detection, sperm quality detection during preparation for pregnancy, and infertility treatment monitoring. With frequent at-home testing, more datum can be collected while improving physicians to make more accurate clinical decisions.
INTRODUCTION AND OBJECTIVES:
The EAU guidelines suggest performing semen culture in case of increased leukocytes in semen. However, the clinical significance of this parameter is controversial. Furthermore, since the possible causative role of infections in determining semen parameters alterations, identifying either acute or chronic infections in men presenting for couple's infertility is clinically relevant. We sought to evaluate the prevalence of and the types of bacterial infections in infertile men presenting with neither clinical signs of infections nor an increased number of seminal leukocytes.
METHODS: Complete data from 873 consecutive patients seeking medical help for couple's infertility, asymptomatic for genital infections and without an increased number of leucocytes at the semen analysis were analysed. Testes volume was assessed through a Prader orchidometer. Health-significant comorbidities were scored by means of the Charlson Comorbidity Index (CCI) (CCI; categorized 0 vs !1).
Semen cultures were obtained from every man, after having ruled out both urethritis and bladder infections. Polymerase chain reaction (PCR) DNA was used to identify Chlamydia trachomatis and Ureaplasma urealyticum in the semen. A concentration of !10 3 cfu/ mL urinary tract pathogens in the ejaculate was considered suggestive for significant bacteriospermia. Leukocytospermia was defined as more that 10 3 leukocytes in the ejaculate at the semen analysis.
RESULTS: Of 873, 96 (11%) and 777 (89%) men presented a positive and a negative semen culture, respectively. No significant differences in terms of clinical parameters were observed between men with positive or negative semen culture. Total testosterone was lower in the group with positive semen culture despite no leukocytospermia (median 4.6 (IQR 3.5-5.8) vs 3.9 (IQR 3.0 -5.7); p 0.05). The most commonly identified infections were Ureaplasma urealitycum (35%) and Enterococcus faecalis (31%), followed by Staphylococcus aureus (7%), Chlamidya trachomatis (6%), Streptococcus faecalis (4%) and others (17%).
CONCLUSIONS: Despite the absence of signs and symptoms of infection, the prevalence of bacterial infection/colonization in the study cohort is relevant. Identifying this condition in asymptomatic infertile men may be helpful to potentially improve semen and sperm quality. Whether our results eventually reflect the presence of a true bacterial infection or an altered testis microbial composition needs to be addressed with further preclinical studies.
Source of Funding: none
MP46-12 CAN SEMEN PARAMETERS PREDICT CHROMOSOMAL ANOMALY IN MALE FACTOR INFERTILITY?
Chiung-Kun Huang*, Wei-Jen Chen, I-Shen Huang, Eric Yi-Hsiu Huang, William J.S. Huang, Taipei, Taiwan INTRODUCTION AND OBJECTIVES: We aim to investigate the prevalence of chromosomal abnormalities, AZF microdeletions and partial AZFc deletions in male infertility patients, and also to determine clinical thresholds of semen parameters for positive genetic testing in infertile men.
METHODS: We retrospectively analyzed infertile men who received karyotype and Y chromosome microdeletion analysis from 2006 to 2017. The correlation of semen analysis data, including sperm count, motility and morphology, and the findings of genetic testing were examined. Univariate logistic regression analysis was conducted to compare the semen parameters of those with or without genetic abnormalities (chromosome abnormalities, AZF microdeletions and partial AZFc deletions). Various different thresholds of seminal parameters were set (sperm concentrations: 0.1, 0.5, 1, 5 million/ml and motility: 10%, 20%, 30%, 40%, respectively) to evaluate the odds ratio for detection of genetic anomaly in infertile men.
RESULTS: A total of 1222 infertile men were analyzed, including 767 azoospermic, 264 severe oligozoospermic, 85 oligozoospermic and 106 intermittent normozoospermic men. Of them, 206 (16.85%) were diagnosed chromosomal abnormalities; AZF microdeletions and partial AZFc deletions were noticed in 104 (8.51%) and 276 (22.58%) in our cohort. Chromosome abnormalities, AZF microdeletions and partial AZFc deletions were detected in 22.6%, 10.8% and 24.1% in azoospermic men. Sperm concentration and motility were both signiï: cant predictors for the identification of genetic abnormalities. Sperm concentration set at various specific level, 0.5, 1 and 5 million/ml, have the higher odds ratio to detect chromosome abnormalities (OR[ 3.436, 95% CI 2.232w5.290, p<0.001), AZF microdeletions (OR[13.324, 95% CI 4.195w42.316, p<0.001) , and partial AZFc deletions (OR[1.675, 95% CI 1.09w2.553, p[0.016) . Sperm motility cut-off value at 20% have an odds ratio of 2.506 (95% CI 1.623w3.868, p[0.001) for prediction of chromosome abnormalities; cut-off value at 10% can predict the possibility of AZF microdeletions with an odds ratio of 5.356 (95% CI 2.575w11.14, p<0.001). While
